Introduction
Accurate distribution of a duplicated genome over two daughter cells requires condensed chromosomes, a perfect spindle, and a mechanism that ensures correct attachment of these chromosomes to the spindle prior to cell division. Here we discuss the involvement of Pololike kinase-1 (Plk1) in the broad range of processes from start to completion of mitosis. In the family of Polo-like kinases, Plk1 is the human homolog of the founding member Polo in Drosophila. The original identification of Polo (Drosophila), Cdc5 (S. cerevisiae) and Plo1 (S. pombe) by mutational analysis, revealed an essential role for Polo-like kinases (Plk's) in mitotic progression. In human cells, four Polo-like kinases have been identified, based on the presence of one or more polo-boxes (Plk1, SNK or Plk2, Fnk/Prk or Plk3 and Sak or Plk4, recently reviewed in Barr et al. (2004) . In human cells, Plk1 appears to be responsible for the main portion of Poloand Cdc5-related functions, and therefore this review mainly covers recent advances made in Plk1-related research.
Plk's are serine/threonine kinases that typically exist of an N-terminal kinase domain and harbor one (Plk4) or two (Plk1-3) polo box domains. Plk1 is expressed from G2 onwards and is degraded at the end of mitosis (Uchiumi et al., 1997; Fang et al., 1998; Lindon and Pines, 2004) . Although Plk1 is already present in G2, its kinase activity is first seen at the G2/M transition and reaches peak levels during mitosis (Golsteyn et al., 1995) . Little is known about the upstream regulation of Plk1. However, by mutational analysis, two putative phosphorylation sites (Ser128 and Thr201) were identified in the Xenopus homolog Plx1 (Qian et al., 1999) . Subsequently, xPlkk1, an upstream kinase for Plx1, was cloned from Xenopus and shown to phosphorylate Thr201 in vitro (Qian et al., 1998b (Qian et al., , 1999 . Although no in vivo evidence exists for a human Plk1-kinase, two xPlkk1-related kinases were shown to phosphorylate Plk1 in vitro (Ellinger-Ziegelbauer et al., 2000; Walter et al., 2003) . Recently, mass spectrometric analysis of Plx1 revealed additional phosphorylation sites, including two autophosphorylation sites . In addition to the identified Plkk's, Cyclin B-Cdk1 was also suggested to function as an activating kinase for Plk1. Indeed, Cyclin B-Cdk1 can phosphorylate human Plk1 and Xenopus Plx1 in vitro, but the identified Cdk1-consensus motif in Plx1 (S304) is not conserved in human Plk1. Thus, it is unclear if and how Cdk1 can function as a bona fide upstream kinase for Plk1 in vivo (Hamanaka et al., 1995; Kelm et al., 2002) .
More recently, a model was proposed for Plk1 activation, in which the Polo-box domain rather than an upstream kinase plays a central role (Elia et al., 2003b) . Binding of the polo box domain to a phosphorylated target results in conformational changes that releases the inhibitory effect of the polo-box domain towards the kinase domain. In this model, Plk1 is not directly activated by upstream kinases, but is coupled to the activity of other kinases, such as Cyclin B-Cdk1. In doing so, kinases with specific temporal or spatial activities, phosphorylate future Plk1 substrates that subsequently recruit Plk1. In this way, Plk1 can amplify signaling pathways or rather act as a switch that only fires when multiple requirements are met. This of course does not preclude a role for upstream kinases in regulating Plk1 through additional phosphorylation events.
In recent years, a range of molecular targets of Plk1 has been identified that revealed the signaling pathways by which Plk1 can regulate mitotic entry, DNA damage checkpoint responses, spindle formation and mitotic exit. In the following sections, we discuss these targets and their actions and discuss implications for tumorigenesis and cancer therapy.
Plk1 and mitotic entry
All cell cycle transitions, such as mitotic entry, are driven by the activity of specific Cyclin-dependent kinases (Cdk's), bound to their cognate Cyclins. Cyclin subunits are expressed in a cell cycle-dependent fashion that promotes a forward (one-way) direction in cell cycle progression. The transition from G2 to mitosis strictly depends on activation of the MPF (M-phase-promoting factor), which consists of Cdk1 in complex with Cyclin B (reviewed in Morgan, 1995) . In G2, enhanced promoter activity as well as increased stability of Cyclin B mRNA result in sufficiently high amounts of Cyclin B protein (Pines and Hunter, 1989; Maity et al., 1995; Piaggio et al., 1995) . This newly synthesized Cyclin B can now bind the inactive Cdk1, but does not result in an active nuclear Cyclin B-Cdk1 complex yet, because the complex is kept inactive by different signaling pathways (Figure 1, upper panel) .
Firstly, Cdk1 is phosphorylated by Wee1 and Myt1 in its ATP-binding site on Tyr15 (by Wee1 and Myt1) and Thr14 (by Myt1) kinases (Atherton-Fessler et al., 1993; Booher et al., 1997) . Phosphorylation on these sites prevents ATP-binding of Cdk1 and thereby keeps the Cyclin-Cdk1 complex catalytically inactive. Secondly, Cyclin B-Cdk1 complexes are regulated by subcellular localization. Unlike Cyclin A, which seems to be always nuclear, Cyclin B is localized predominantly in the cytoplasm during interphase (Pines and Hunter, 1991) . In fact, Cyclin B is continuously shuttled in and out of the nucleus in G2, but because nuclear export dominates import at this stage, the bulk of the protein is cytoplasmic (Hagting et al., 1998) . To facilitate this transport, Cyclin B harbors two domains that control cytoplasmic-nuclear shuttling; a nuclear localization signal (NLS) that targets Cyclin B-Cdk1 complexes to Figure 1 Mitotic entry and the G2 DNA damage checkpoint. In G2, premature mitotic entry is prevented through inhibitory phosphorylation on Cdk1 as well as nuclear export of Cyclin B (upper panel). Plk1 is implicated in several processes that contribute to the activation of Cyclin B-Cdk1 (middle panel). Plk1 directly phosphorylates Wee1, Myt1, Cyclin B and Cdc25C. Phosphorylation of Wee1 results in its degradation. In contrast, phosphorylation of Cyclin B and Cdc25C, promotes Cyclin BCdk1 activation at the centrosome, and likely involves feedbackloop amplification. Whether Plk1 also signals inhibition towards Myt1 is unclear. In response to DNA damage, the G2 DNA damage checkpoint prevents mitotic entry (lower panel), Activation of checkpoint kinases ATM, ATR, Chk1, Chk2 and p38 mediate nuclear exclusion of Cdc25C and Cdc25B, degradation of Cdc25A, activation of Wee1 and inhibition of Plk1. As a result, checkpoint signaling results in sustained Y15-phosphorylation and an inactive Cdk1-Cyclin B complex the nucleus in an atypical Importin-b-dependent fashion (Moore et al., 1999; Takizawa et al., 1999) , and a cytoplasmic retention signal (CRS), harboring an NES (Nuclear Export Signal), which mediates Crm1-dependent nuclear export and ensures cytoplasmic localization of Cyclin B-Cdk1 before mitotic onset (Pines and Hunter, 1994; Hagting et al., 1998; Yang et al., 1998) .
Entry into mitosis requires full Cyclin B-Cdk1 activity and depends on phosphorylation of Thr161 (located in the T-loop of Cdk1) and dephosphorylation of Tyr15 and Thr14. The CAK complex (consisting of Cdk7, Cyclin H and MAT1) was shown to be responsible for phosphorylation of Thr161, resulting in increased kinase activity of the Cyclin B-Cdk1 complex (Fesquet et al., 1993; Poon et al., 1993; Solomon et al., 1993; Fisher and Morgan, 1994) . Dephosphorylation of Tyr15 and Thr14 is brought about by all members of the Cdc25 phosphatase family (Cdc25A, B, and C) (Sadhu et al., 1990; Galaktionov and Beach, 1991; Nagata et al., 1991) . In the process of Cdk1-dephosphorylation at the G2/M transition, Cdc25B is thought to act as a starterphosphatase that initially activates cytoplasmic Cyclin B-Cdk1 (Gabrielli et al., 1996; Lammer et al., 1998) . Once activated, Cyclin B-Cdk1 effectively promotes its own full and rapid activation in a dual positive amplification loop; Cyclin B-Cdk1 activates Cdc25C by phosphorylation to further promote Cdk1-dephosphorylation ( Figure 1 , middle panel) (Hoffmann et al., 1993) . In addition, Cyclin B-Cdk1 phosphorylates Wee1 to promote its degradation and in this way decreases Cdk1-phosphorylation on Tyr15 (Watanabe et al., 2004) . Thus, the amplification loop that controls Cyclin B-Cdk1 activity ensures mitotic commitment once mitotic entry has started. Mitotic entry is also characterized by a rapid accumulation of Cyclin B-Cdk1 in the nucleus. Preventing nuclear import of Cyclin B blocks mitotic entry, illustrating the importance for nuclear localization of this complex (Li et al., 1997) . Moreover, expression of an active Cdk1 mutant that is constitutively localized in the cytoplasm cannot accelerate mitotic entry (Heald et al., 1993) , again indicating that a collaboration between Cdk1 activation as well as Cyclin retention in the nucleus controls mitotic entry. This is further supported by the notion that expression of a constitutively nuclear mutant of Cyclin B1 or a Cdk1 mutant lacking the inhibitory Thr14/Tyr15 phosphorylation sites partially overrides a DNA damage-induced G2 arrest, while the combined expression of both mutants results in a full checkpoint override (Jin et al., 1998) .
Polo-like kinases were suggested to regulate Cyclin BCdk1 activity at several levels ( Figure 1, middle panel) . The Xenopus Polo-like kinase Plx1 was shown to directly phosphorylate and activate Cdc25C (Kumagai and Dunphy, 1996) , and actually be part of the MPF amplification loop (Abrieu et al., 1998; Qian et al., 1998a) . Indeed, depletion of Plx1 prevented Cdc25C hyperphosphorylation and delayed Cyclin B-Cdk1 activation (Qian et al., 1998a) . Recently, elegant work of Elia et al. (2003a, b) provided a molecular view of the amplification loop in MPF by demonstrating that the polo box of Plk1 is a phospho-binding domain that determines binding to Cdc25C, once Cdc25C is primed by Cdk-phosphorylation. Human Plk1 was also shown to phosphorylate Cdc25C and thereby activate as well as mediate nuclear translocation of Cdc25C (Smits et al., 2000; Toyoshima-Morimoto et al., 2002) . The contribution of this phosphorylation event to Cyclin B-Cdk1 activity, however, is doubtful, since Plk1-depleted cells enter mitosis with active Cyclin B-Cdk1 but incompletely phosphorylated Cdc25C (van Vugt et al., 2004a) . Therefore, the requirement for Cdc25C during mitotic entry may differ between species or between different kinds of cell division cycles.
Plk1 was recently also shown to regulate Cdk1-phosphorylation via another mechanism. Through direct phosphorylation of Wee1, Plk1 was shown to promote degradation of Wee1 and thereby decrease Cdk1 phosphorylation (Watanabe et al., 2004) . This study showed that Wee1 is phosphorylated by Cyclin BCdk1 as well as by Plk1. It could very well be that this dual phosphorylation is kicked off by a Cdk1-phosphorylation that primes Wee1 for phosphorylation by Plk1 to create a 'phosho-degron' that is recognized by the b-TrCP-SCF (Watanabe et al., 2004) . These observations do suggest that binding of Plk1 to mitotic regulators that are primed by Cdk-phosphorylation is a common theme for Plk1-mediated actions (Elia et al., 2003b) . Whether Plk1 regulates another Cdk1 kinase, Myt1, via a similar mechanism remains to be elucidated. However, using a Plk1 consensus phosphorylation motif, the Wee1-family member Myt1 was identified as an in vitro Plk1 substrate. In addition, also Cyclin BCdk1 is able to phosphorylate Myt1 in vitro, but whether these phosphorylation events regulate in vivo inactivation has to be determined (Booher et al., 1997; Nakajima et al., 2003) .
Besides regulating Cyclin B-Cdk1 activity, Plk1 was also proposed to regulate the subcellular localization of this complex. Initially, Plk1 was proposed to fulfill this role through phosphorylation of Ser147, located in the NES of Cyclin B (Toyoshima-Morimoto et al., 2001) . This phosphorylation was suggested to disrupt the NES of Cyclin B and result in nuclear retention of Cyclin BCdk1. Subsequently, Plk1 was shown to phosphorylate Cyclin B just outside the NES at Ser133 (but not Ser147) in order to activate Cyclin B-Cdk1 at the centrosome and promote nuclear import in this way (Yuan et al., 2002a; Jackman et al., 2003) . Yet, the fact that deletion of this phosphorylation site did not block nuclear import of Cyclin B-Cdk1 indicates that multiple factors control nuclear localization of the MPF.
It is clear that the activity of Cyclin B-Cdk1 is precisely controlled by the balance between phosphatase activity (Cdc25A, B and C) and kinase activity (Wee1 and Myt1). However, the initial trigger that causes Cyclin B-Cdk1 activation and drives cells past a point of no return to ensure mitotic commitment remains a big mystery. It is clear that in an unperturbed cell cycle Cyclin B-Cdk1 activation is not allowed until DNA replication is completed, but the underlying mechanism that explains the lag between the completion of S phase and the onset of mitosis, known as G2 phase, is not resolved. Possibly, silencing of the replication checkpoint needs a certain amount of time. In addition, activation of Cdc25B, proposed to act as a starter phosphatase, could play an important role in the timing of mitotic entry. However, Cdc25B was shown to be activated by Cyclin A-Cdk2 and Cyclin A-Cdk2 activity is present from S phase onwards (Gabrielli et al., 1997) . Moreover, deletion of the Cdc25B gene does not block somatic cell division, so additional levels of regulation must exist (Lincoln et al., 2002) . Interestingly, more and more evidence is accumulating that the (maturing) centrosome could play a key role in the initial activation of Cyclin B-Cdk1. Immunocytochemically, a fraction of Cdk1 that is bound to Cyclin B was shown to localize to centrosomes during interphase (Bailly et al., 1989 (Bailly et al., , 1992 . Initially, this localization pattern was suggested to regulate centrosome functioning. More recently, however, accumulation of Cyclin BCdk1 complexes at centrosomes, appeared to coincide with the initial activation of this complex (Jackman et al., 2003) . In addition, Chk1 and Chk2, two negative regulators of Cyclin B-Cdk1, were also shown to be localized to centrosomes (Tsvetkov et al., 2003; Kramer et al., 2004) . Very recently, Kramer et al. (2004) showed that Chk1 is present at centrosomes to prevent premature Cyclin B-Cdk1 activation. Moreover, Chk1 was shown to recruit Cdc25B to centrosomes, and at the same time keep Cdk1 temporarily inactive. Taken together, these data show that the centrosome may function as a platform for timely Cyclin B-Cdk1 activation. Since Plk1 is present at centrosomes and is responsible for Cyclin B phosphorylation at this site (Golsteyn et al., 1995; Jackman et al., 2003) , could Plk1 be responsible for initial activation of Cyclin B-Cdk1? Injection of anti-Plk1 antibodies in primary human cells or depletion of Plx1 from Xenopus extracts does result in G2 arrest and argues in favor of this idea (Lane and Nigg, 1996; Qian et al., 1998a Qian et al., , 2001 ). However, injection of anti-Plk1 antibodies in transformed human cells, expression of dominant-negative Plk1 fragments and RNA interference of Plk1 in a range of human cells did not result in G2 arrest but rather caused a mitotic arrest with high Cyclin B-Cdk1 levels (Lane and Nigg, 1996; Liu and Erikson, 2002; Seong et al., 2002; SpankuchSchmitt et al., 2002; van Vugt et al., 2004b) . Likely, mitotic entry requires multiple factors, and only in some cell types or situations does Plk1 become rate limiting for this process.
Plk1 and G2-M checkpoints
To allow cells time to repair damaged DNA, a complex network called the 'DNA damage checkpoint' prevents Cyclin-Cdk activation and arrests cell cycle progression. Accordingly, when cells encounter DNA damage in G2, the 'G2 DNA damage checkpoint' inhibits Cyclin BCdk1 activity to prevent mitotic entry (Figure 1 , lower panel) (reviewed in Elledge, 1996) . Different types of DNA damage can activate the G2 DNA damage checkpoint and induce a G2 arrest. However, it should be noted that the G2 DNA damage checkpoint is particularly useful for repair of double-strand breaks because the duplicated genomic material offers cells the possibility to use the duplicated chromatids as templates for the high-fidelity homologous recombination (HR) repair system (Haber, 2000) . This opportunity is limited in a temporal fashion, since sister chromatids are separated during mitosis and as a result neighboring templates for HR will be lost.
DNA damage results in the activation of checkpoint kinases ATM and ATR, which subsequently signal to a range of checkpoint mediators, such as p53, Chk1, Chk2 and Histone H2AX as well as components of DNA repair mechanisms (reviewed in Shiloh, 2003) . Subsequently, activation of this checkpoint pathway results in inactivation of all Cdc25 family members. Conversely, checkpoint activation enhances Wee1 function, and as a net result the balance between positive and negative regulators generates an Y15-phosphorylated, inactive Cyclin B-Cdk1 complex. Also, Plk1 was shown to be a direct target of the G2 DNA damage checkpoint ( Figure 1 , lower panel) (Smits et al., 2000) . In response to a range of DNA-damaging agents, Plk1 was shown to be catalytically inactivated. Moreover, this inhibition was shown to depend on functional ATM or ATR (van Vugt et al., 2001) . The relevance of this inhibition was illustrated by the fact that expression of constitutively active Plk1-mutants can override the DNA damageinduced G2 arrest (Smits et al., 2000) . In addition, since Plk1 is inhibited in response to DNA damage, a picture is emerging in which all proteins involved in Cyclin BCdk1 regulation are targets of the DNA damage checkpoint, in such a way that mitotic entry is inhibited at all costs ( Figure 1 , lower panel).
Whereas Plk1 is inhibited in response to DNA damage, Plk3 was shown to be activated after treatment with DNA damaging agents (Xie et al., 2001) . Moreover, activation of Plk3 was shown to coincide with cell cycle arrest and increased interaction and phosphorylation of p53 by Plk3. Thus, Plk1 and Plk3 appear to have counteracting rather than overlapping roles in mitotic entry. Indeed, whereas Plk1 was shown to mediate nuclear translocation of Cdc25C, Plk3 phosphorylates Cdc25C on Ser216, a site known to be involved in nuclear exclusion (Ouyang et al., 1999; ToyoshimaMorimoto et al., 2002) . The exact mechanism by which Plk3 regulates the G2/M transition in general and Cdc25C in particular is unclear however, as a recent report showed that Cdc25C translocates to the nucleus after (direct) phosphorylation by Plk3 (Bahassi el et al., 2004) .
Not only DNA damage activates a checkpoint at the G2-M transition. All kinds of stress feed into checkpoint signaling, and inhibit Cyclin B-Cdk1 activation. In response to altered microtubule dynamics for instance, the ubiquitin-ligase Chfr was shown to be activated and responsible for delayed mitotic entry (Scolnick and Halazonetis, 2000) . Interestingly, activation of this so-called 'prophase-checkpoint' was suggested to result in ubiquitination-mediated degradation of Plk1 via Chfr (Kang et al., 2002) . Through downregulation of Plk1, the prophase checkpoint would lead to inhibition of Cdk1 activity. More recent data confirm that this checkpoint requires protein ubiquitination, but also demonstrate that proteasomal degradation is not involved (Matsusaka and Pines, 2004) . In fact, Matsusaka and Pines (2004) did not observe Plk1 degradation following activation of the prophase checkpoint. Thus, the exact nature of this checkpoint and its role in controlling cell cycle progression remains largely unknown.
Polo-like kinases and cell cycle resumption after a checkpoint arrest
In addition to being a target of the DNA damage checkpoint, Polo-like kinases were also shown to regulate cell cycle progression after a damage-induced cell cycle arrest. The first evidence for such a role was provided by experiments done in S. cerevisiae mutants that are unable to repair double strand breaks. Yeast cells ultimately escape the DNA damage checkpoint arrest in a process called 'adaptation'. Such a mechanism allows damaged cells to eventually divide and possibly survive. Alternatively, these cells are allowed to repair their DNA damage in the subsequent G1. Although the exact mechanism of checkpoint adaptation remains unclear, the inactivation of Rad53 seems to be a key switch. In agreement with this notion, yeast strains lacking functional PP2C phosphatases (known to inactivate Rad53) cannot adapt in response to a doublestrand break (Leroy et al., 2003) . Interestingly, strains carrying a mutant form of Cdc5 (the Plk1-homolog in budding yeast) were also unable to perform adaptation (Toczyski et al., 1997) .
Since yeast cells do not run the risk of developing cancer, 'adaptation' for these cells can be beneficial to help population survival. In contrast, a leaky checkpoint poses a serious threat to the genomic integrity of a cell and can potentially cause malignancies in multicellular organisms. Therefore, the 'adaptation' process was long thought to be limited to single-cell organisms. However, this notion was challenged by Dunphy and co-workers, who provided evidence for checkpoint adaptation in response to stalled replication forks in Xenopus extracts (Yoo et al., 2004) . Interestingly, Plx1 was shown to be required during this checkpoint adaptation. In this process, Plx1 was shown to displace the checkpoint mediator Claspin from chromatin through direct phosphorylation (Yoo et al., 2004) . Here again, Plx1 was reported to dock to its substrate (Claspin), once this substrate had been 'primed' by phosphorylation. In this case, the priming kinase was shown to be the Xenopus homolog of ATR (Figure 2) (Yoo et al., 2004) . This observation extends the number and nature of priming kinases that can direct Plk1 to its future substrate and shows the versatility of this system (for a list see Figure 3b ) (Elia et al., 2003a; Yoo et al., 2004) . The Xatr phosphorylation site S904 is conserved between Xenopus and humans. However, while S904 is located in an ATM/ATR consensus site in Xenopus Claspin, it resides in a Cdk1 consensus motif in human Claspin. So whether Plk1-Claspin mediated adaptation is conserved in all multicellular organisms remains to be clarified.
But more importantly, why would multicellular organisms perform adaptation? One reason could be that adaptation allows the clearance of cells with irrepairable damage through mitotic catastrophe. Indeed, evidence is present for a mechanism in which mitotic entry in the presence of DNA damage can lead to cell death via mitotic catastrophe (Nitta et al., 2004) . Another reason for adaptation in multicellular organisms could lie in the fact that in G1 other (more favorable) types of DNA damage repair are available. For double-strand breaks this seems unlikely since the duplicated sister chromatids in G2 create optimal conditions for HR. For stalled replication, however, alternative repair mechanisms may be present in G1.
To date, evidence for checkpoint adaptation in mammalian cells is lacking. However, human cells are expected to restart the cell cycle once DNA damage is completely repaired. In fact, Plk1 was recently shown to play a role in this recovery-process through regulation of Cdk1 phosphorylation (van Vugt et al., 2004a) . Both Plk1 as well as Cdc25B were shown to be required for efficient mitotic entry, once the G2 DNA damage checkpoint was silenced. These results indicate a clear difference between damaged and undamaged cells. Whereas depletion of Plk1 or Cdc25B did not notably affect mitotic entry in an unperturbed cell cycle, damaged cells critically required Plk1 and Cdc25B for mitotic entry after checkpoint silencing (van Vugt et al., 2004a) (see also Figure 2 ). These results indicate that damaged and undamaged cell cycles are wired fundamentally different.
Checkpoint recovery driven by Plk1 was shown to involve the degradation of Wee1 triggered through direct phosphorylation by Plk1 (Figure 2 ) (van Vugt et al., 2004a) . However, as Wee1 degradation was suggested to depend on phosphorylation by both Plk1 and Cyclin B-Cdk1, it is not unlikely that small amounts of Cyclin B-Cdk1 are required to establish its own amplification loop through Plk1 after a DNA damage arrest (Watanabe et al., 2004) . This would be consistent with earlier observations made in yeast, where Cyclin B-Cdk1 activity is required to inactivate checkpoint signaling and promote re-entry into the cell cycle through phosphorylation of Crb2 (Esashi and Yanagida, 1999) .
At first glance it seems contradictory that Plk1 is both a target of the DNA damage checkpoint as well as an essential component of the restart mechanism after checkpoint inactivation (Smits et al., 2000; van Vugt et al., 2001 van Vugt et al., , 2004a . However, Plk1 must be efficiently inhibited to ensure proper checkpoint functioning (Smits et al., 2000) . Thus, this apparent contradiction would be resolved if Plk1 were to be inactivated by checkpoint kinases as long as the damage persists. Indeed, Plk1 activity was only restored when DNA damage checkpoint signaling was silenced, and Cyclin B-Cdk1 activation as well as mitotic entry were only observed in cells expressing Plk1 (van Vugt et al., 2004a) , consistent with a role for Plk1 as the trigger kinase during recovery.
As DNA damage is repaired, checkpoint signaling will cease and (constitutively active) phosphatases can revert the inhibition enforced by checkpoint kinases so that Plk1 activity is allowed to rise. The identity of the phosphatases involved in the reversion of the checkpoint When the G2 DNA damage checkpoint is activated in response to UV or double-strand breaks in mammalian cells, ATM/ATR kinases are activated and subsequently activate Chk1/Chk2. Chk1, Chk2 or p38 inhibit Cdc25C and Cdc25B, promote degradation of Cdc25A and activate Wee1 to prevent activation of Cyclin B-Cdk1 (lower-left panel). During recovery after checkpoint silencing, Plk1 and Cdc25B are both required for Cyclin B-Cdk1 activation and subsequent mitotic entry (lower-right panel). Plk1 (possibly in combination with Cyclin B-Cdk1) is required for Wee1-degradation during this process through direct phosphorylation signaling cascades is currently unknown, but in yeast phosphatases were recently identified that are required for a restart of the cell cycle following DNA damage (Leroy et al., 2003; Den Elzen and O'Connell, 2004) . The PP2-related phosphatases Ptc2 and Ptc3 regulate Rad53 and are required for efficient recovery as well as adaptation in S. cerevisiae (Leroy et al., 2003) . The PP1-related Dis2 phosphatase reverses Chk1 phosphorylation by Rad3 (the fission yeast homolog of ATR), and was shown to be required for recovery from a DNA damage arrest in S. pombe (Den Elzen and O'Connell, 2004) . However, the precise role of related phosphatases in recovery in mammalian cells remains to be identified. Interestingly, the mammalian PP2d-phosphatase Wip1 was shown to be required for recovery after a UVinduced arrest through dephosphorylation of p38 (Takekawa et al., 2000) . Whether such a mechanism also regulates Chk1/Chk2 activity in mammalian cells and whether PP1-related phosphatases are also involved in checkpoint recovery requires further research. In addition, it would be interesting to see whether Plk's regulate such phosphatase activity during checkpoint inactivation, especially since yeast cells with mutant Cdc5 are unable to dephosphorylate Rad53 and Chk1 (Pellicioli et al., 2001 ).
Plk1 and mitotic spindle formation
Loss-of-function studies on Polo-like kinases in a range of organisms, from yeast to mammals, showed severe mitotic spindle defects (Sunkel and Glover, 1988; Llamazares et al., 1991; Kitada et al., 1993; SpankuchSchmitt et al., 2002; van Vugt et al., 2004b) . In Drosophila for instance, Polo mutants displayed a high percentage of monopolar spindles, or bipolar spindles with one of the poles displaying an abnormal morphology (Sunkel and Glover, 1988) . Similarly, in human cells interference with the function of Plk1 results in the formation of monopolar spindles (Lane and Nigg, 1996; van Vugt et al., 2004b) . This is not due to a block in centrosome duplication, but a consequence of impaired centrosome maturation and separation. Multiple aspects of centrosome function appear to be affected in Plk1-deficent cells. For one, Plk1 was reported to regulate spindle morphology through g-tubulin recruitment to centrosomes (Lane and Nigg, 1996) . Although Plk1 was shown to directly bind to g-tubulin (Feng et al., 1999) , regulation of tubulin-nucleation at the centrosome probably involves multiple Plk1-interacting proteins. Ninein-like protein (Nlp) and OP18/Stathmin, both shown to be directly interacting with Plk1, are negative regulators of microtubule nucleation (Budde et al., 2001; Casenghi et al., 2003) . Moreover, both Nlp and Stathmin are phosphorylated by Plk1 and at least for Nlp, this results in displacement from centrosomes to allow tubulin-nucleation (Casenghi et al., 2003 (Yarm, 2002) . However, TCTP looses its association with the mitotic spindle during the meta-to-anaphase transition and Plk1 is localized to kinetochores up to metaphase, which suggests a model in which TCTP on microtubules can be phosphorylated by Plk1 only when microtubules attach to kinetochores, potentially resulting in stabilization of the attached microtubule (Arnaud et al., 1998; Gachet et al., 1999; Yarm, 2002) . Whether Plk1 also regulates the human homolog of Drosophila Asp remains to be established.
The observed requirement for Plk1 to form a bipolar spindle could well be the most important function of Plk1 during somatic cell cycles. For one because most of the observed phenotypes after interference with Plk1 function concern defects in spindle morphology, giving rise to a mitotic arrest (Lane and Nigg, 1996; Liu and Erikson, 2002; Seong et al., 2002; Spankuch-Schmitt et al., 2002; Kraft et al., 2003; van Vugt et al., 2004b) . However, more importantly, strikingly similar mitotic defects are observed in Plk1-deficient cells when compared to cells treated with monastrol, a drug that causes the formation of monopolar spindles by inhibiting centrosome separation (van Vugt et al., 2004b) . Inactivation of the spindle checkpoint in Plk1-deficient or monastrol-treated cells allows these cells to exit mitosis, and midbody formation and cleavage furrow ingression were not affected, despite the lack of a bipolar spindle in both conditions (van Vugt et al., 2004b) . This strongly suggests that the centrosome defects are the prime defects that arise after interfering with Plk1 function, while other phenotypes may arise as a secondary consequence of the impaired spindle function. In addition, these observations underline the limited role for Plk1 during mitotic entry in unperturbed cell cycles.
Plk1 and APC activation
The anaphase-promoting complex or cyclosome (APC/ C) is a multisubunit ubiquitin ligase that targets a range of mitotic proteins for proteasomal degradation. The APC/C is regulated both by phosphorylation and by binding to ancillary proteins of the 'WD-repeat' family: Cdc20 and Cdh1 (Peters, 2002) . From prophase to metaphase, the APC/C binds Cdc20, while Cdh1 is phosphorylated by Cyclin B-Cdk1 complexes and unable to bind the APC/C at these stages of mitosis. However, when Cyclin B-Cdk1 is degraded in metaphase, inhibitory phosphorylation on Cdh1 is lost through dephosphorylation, and Cdh1 can now bind and activate the APC/C. Cdc20-dependent APC/C ubiquitinates D-box-containing proteins including Btype Cyclins and securin. In contrast, the Cdh1-activated APC/C targets proteins for destruction that contain either a D-Box or a KEN-box, such as Cdc20, Aurora kinases and Plk1 (Shirayama et al., 1998; reviewed in Peters, 2002) .
During the early stages of mitosis, Cdc20 is kept inactive by the spindle assembly checkpoint. The inhibitory signal towards Cdc20 emitted by the spindle assembly checkpoint is essential for proper chromosome segregation, as it prevents the resolution of the cohesive linkage between paired sister chromatids before all of the chromosomes have correctly attached to the mitotic spindle (reviewed in Yu, 2002) . This cohesive linkage is formed by a multi-subunit ring-structure called cohesin. Cleavage of cohesin is dependent on a cysteine protease, separase, that in turn is inhibited through binding to the scaffold protein securin (Ciosk et al., 1998) . At metaphase, securin is targeted for ubiquitin-mediated destruction by Cdc20-dependent APC/C, and separase can subsequently cleave cohesin, allowing the sister chromatids to separate (Cohen-Fix et al., 1996; Visintin et al., 1997) . As Cdc20 is inhibited as long as not all chromosomes have attained bipolar attachment, cohesin degradation cannot take place before metaphase, so that unequal distribution of chromatids and subsequent aneuploidy in daughter cells is prevented (Jallepalli et al., 2001) . It should be noted that degradation of some Cdc20-APC/C targets is allowed even before the spindle assembly checkpoint is silenced. For instance, Cyclin A and Nek2A are degraded as soon as cells enter mitosis, independently of spindle checkpoint inactivation (den Elzen and Pines, 2001; Geley et al., 2001; Hames et al., 2001) . However, it remains unclear how the Cdc20-APC/C can distinguish between targets that need to be degraded before and after spindle checkpoint inactivation.
The APC/C is jointly regulated through phosphorylation by Cyclin B-Cdk1, Polo-like kinases as well as PKA (Kotani et al., 1998; Zachariae and Nasmyth, 1999; Rudner and Murray, 2000; Golan et al., 2002; Kraft et al., 2003) . Whereas Cyclin B-Cdk1 and Plk1 were shown to activate the APC/C, PKA was shown to decrease APC/C activity (Kotani et al., 1998) . Cyclin BCdk1 phosphorylates a range of APC/C subunits, of which 15 phosphorylation sites were confirmed in vivo (Kraft et al., 2003) . In addition, Cyclin B-Cdk1 activity promotes Cdc20-binding to the APC/C and increases its ubiquitin ligase activity (Kotani et al., 1998; Golan et al., 2002; Kraft et al., 2003) . The significance of APC/ C phosphorylation by Cyclin B-Cdk1 was underlined by mutational analysis; removal of Cyclin B-Cdk1 sites in subunits of the yeast APC/C prevented Cdc20-binding and abolished APC/C activity (Rudner and Murray, 2000) .
Polo-like kinases were also shown to be regulators (as well as targets) of the APC/C. In particular, activity of Polo-like kinases was shown to be required for degradation of mitotic Cyclins in yeast and Xenopus cells (Descombes and Nigg, 1998; Shirayama et al., 1998) . A range of APC/C subunits is phosphorylated by Plk1 in vitro, including APC6 (or Cdc16), APC3 (or Cdc27), APC1 (or Tsg24), APC5 and Cdc23 (Kotani et al., 1998; Golan et al., 2002; Kraft et al., 2003) . This phosphorylation of the APC/C by Plk1 was shown to increase ubiquitin ligase-activity in vitro (Kotani et al., 1998; Golan et al., 2002) . However, determination of in vivo APC/C phosphorylation only confirmed few of the sites that were reported to be phosphorylated in vitro (Kraft et al., 2003) , thus making the impact of APC/C phosphorylation by Plk's unclear. And even though depletion of Plx1 from Xenopus extracts prevented Cyclin B degradation, this may reflect a specific requirement for Plx1-mediated APC activation during exit from meiosis II (Descombes and Nigg, 1998) . In addition, when Cdk1-phosphorylation sites were mutated in yeast APC/C subunits, APC/C was still phosphorylated by the Polo-like kinase Cdc5 in vitro, but APC/C activity was diminished (Rudner and Murray, 2000) . Although it does not rule out a role for Plk1 in APC/C regulation, it does show that Cyclin B-Cdk1 acts as the prime APC/C regulator in vivo. This idea is supported by depletion studies in which human cells lacking Plk1 still degraded the APC/C-Cdc20 target Cyclin A with normal kinetics (Kraft et al., 2003; van Vugt et al., 2004b) . Degradation of another APC/CCdc20 target, Cyclin B, was suggested to be defective after Plk1-depletion (Liu and Erikson, 2002) . However, this observation was shown to be an indirect result of spindle checkpoint activation, rather than an APC/C activation deficiency, as Plk1-depleted cells degraded APC/C-Cdc20 targets Cyclin B and securin after spindle checkpoint inactivation (van Vugt et al., 2004b) . Therefore, the importance of APC/C phosphorylation by Plk1 continues to be unclear. Although Plk1 does not seem essential for APC/C activation, the fact that Plk1 does increase Cdc20-binding and ubiquitin ligase activity of the APC/C when added simultaneously with Cyclin BCdk1, suggests that Plk1 might function to ensure continuous APC/C activity or increase its ability to recognize (a specific subset of) substrates. Also, the fact that simultaneous addition of Cyclin B-Cdk1 and Plk1 resulted in additional phosphorylation of a subset of APC subunits (APC1, APC5 and Cdc23) suggests that priming phosphorylation may also play a role in APC regulation (Figure 3b) (Kraft et al., 2003) .
During interphase, the APC/C must be kept inactive to allow accumulation of A and B-type Cyclins. The Fbox protein Emi1 (early mitotic inhibitor-1) prevents premature APC/C activation and, by doing so, guarantees the capacity for mitotic entry (Reimann et al., 2001a, b) . Emi1 binds to Cdc20, and prevents binding of Cdc20 to APC/C-targets (Reimann et al., 2001b) . In accordance, depletion of Emi1 strongly delays mitotic entry, because of the inability to accumulate sufficiently high levels of mitotic Cyclins. Conversely, proper progression through mitosis requires timely Emi1-degradation, in a process that is regulated by SCF-bTrCP (Guardavaccaro et al., 2003; Margottin-Goguet et al., 2003) . Binding of Emi1 to SCF-b-TrCP was shown to require phosphorylation of Emi1 by Cdk1 and an additional kinase. Recently, this additional kinase was shown to be Plk1 and hence a two-step model was proposed in which Cdk1 primes Emi for Plk1-mediated phosphorylation and subsequent degradation Moshe et al., 2004) . Thus, Plk1 also regulates APC/C in an indirect fashion. However, it should be noted that the contribution of Emi1-phosphorylation by Plk1 to APC/C activation is unclear, since Plk1-depleted cells arrest in mitosis with degraded Cyclin A (Kraft et al., 2003; van Vugt et al., 2004b) .
It is still also unclear if functional redundancy exists between Plk1 and other Plk's in mitotic progression. Plk2 is expressed predominantly during G1/S and was recently shown to play a role in centriole duplication rather than centrosome separation (Warnke et al., 2004) . Like Plk1, Plk3 is expressed mainly in G2/M but likely plays a role that is limited to the G2/M transition (Bahassi el et al., 2004) . In contrast, Plk4 (Sak) was shown to play a role in mitotic progression. Mice embryo's lacking Sak displayed elevated levels of anaphase/telophase cells (Hudson et al., 2001) . Moreover, these Sak À/À cells were positive for Cyclin B, indicative for defective APC/C activation. These findings, in combination with the observed APC/C activation in the absence of Plk1 (Kraft et al., 2003; van Vugt et al., 2004b) , suggest that the Sak may regulate the human APC/C in a fashion similar to that of S. cerevisiae Cdc5 and yeast APC/C. This way, the multiple functions of Cdc5 may be divided over different Plk's in human cells. Future experiments will have to address how specificity of polo-box mediated interaction of the different family members is determined, and whether the different kinase domains contribute to additional levels of specificity when it comes to downstream targets.
Plk1 and condensation/separation of chromosomes
During DNA replication in S phase cohesin is recruited to chromosome arms and centromere regions, and maintains sister-chromatid cohesion. When cells enter mitosis, the chromatin is tightly packed in a process called 'condensation' (reviewed in Hirano, 2000) . This procedure involves recruitment of multisubunit condensin complexes as well as histone phosphorylation and is tightly coupled with the displacement of cohesin complexes from the chromosome arms in prophase. Nonetheless, the linkage between duplicated sisterchromatids is maintained during this stage through residual amounts of cohesin at centromeric regions (Waizenegger et al., 2000) . In metaphase all residual cohesin is then removed from chromosomes through cleavage of its subunit SCC1, to allow chromosome segregation (Uhlmann et al., 1999 Hauf et al., 2001 and reviewed in Nasmyth et al., 2000) .
Polo-like kinases have been implicated to regulate chromosome condensation and separation. The initial examination of Polo mutants in Drosophila revealed hypercondensed chromosomes (Llamazares et al., 1991) . These observations matched later studies that described condensation defects when Plk1-function was interfered with (Losada et al., 2002; Gimenez-Abian et al., 2004; van Vugt et al., 2004a) . In contrast to condensin recruitment, for which no direct involvement for Pololike kinases is described, cohesin removal is directly regulated by Plk's. Involvement of Plk's in cohesin displacement was originally identified in S. cerevisiae. In contrast to vertebrate cells, which remove chromatinbound cohesin in a two-step fashion, yeast cells remove cohesin in one step through separase-mediated cleavage. During cohesin displacement in S. cerevisiae, the cohesin subunit SCC1 is phosphorylated by the Polo-homolog Cdc5 (Alexandru et al., 2001) . This phosphorylation event strongly enhances SCC1-cleavage by separase and is essential for proper chromosome segregation. Recently, phosphorylation of SCC1 by polo-like kinases was shown to restrict cleavage by separase to chromatinbound cohesin (Hornig and Uhlmann, 2004) . Probably, the colocalization of polo-like kinases and cohesin to kinetochores is used to confine cohesin cleavage and conserve cytoplasmic cohesin.
Polo-like kinases also regulate sister-chromatid cohesion in multicellular organisms. Sumara et al. (2002) showed that SCC1-phosphorylation by Plk's is conserved in vertebrates. Using depletion experiments, Xenopus Plx1 was shown to be required for cohesin displacement from chromatin through phosphorylation of SCC1. In vertebrates and higher organisms, however, Plk1-mediated phosphorylation promotes cleavage-independent removal of cohesin, but this removal is restricted to cohesin that is associated to the chromosome arms. Essentially, SCC1 phosphorylated by Plx1 has a markedly decreased affinity for chromatin. In line with this, addition of active Plx1 was sufficient to mediate cohesin-dissociation from chromatin. In addition, human Plk1 was shown to phosphorylate SCC1 in vitro on similar sites as in Xenopus SCC1 (Sumara et al., 2002) . It is unlikely that Plk1-dependent phosphorylation of SCC1 also regulates cleavage of SCC1 by separase after spindle checkpoint inactivation, since cells lacking Plk1 remove SCC1 from chromosomes normally when the spindle checkpoint is inactivated (Gimenez-Abian et al., 2004).
Plk1 and cytokinesis
The observed localization of Plk1 during mitosis nicely fits its proposed role in cytokinesis (Figures 3a and 4) . Similar to chromosome passenger proteins, Plk1 is present at kinetochores from prophase until metaphase and translocates to the central spindle and the midzone in anaphase and telophase, respectively (Golsteyn et al., 1995) . Different molecular interactions were reported to be responsible for this change in subcellular localization (Figure 3) . Two possible docking proteins for Plk1 on the central spindle are the Mitotic Kinesin-like protein-1 and -2 (MKlp1/CHO1 and MKlp2). Plk1 was shown to phosphorylate both MKlp1/CHO1 and MKlp2, which are located on the central spindle (Lee et al., 1995; Adams et al., 1998; Neef et al., 2003; Liu et al., 2004) . For Mklp2, phosphorylation by Plk1 was shown to create a Plk1-binding site (Neef et al., 2003) . In line with these observations, depletion of MKlp1/CHO1 or MKlp2 or deletion of the Plk1-phosphorylation sites in MKlp1/Cho1 or MKlp2 disrupts Plk1 localization to the central spindle (Lee et al., 1995; Adams et al., 1998; Neef et al., 2003; Liu et al., 2004) . Similar observations were made with the Golgi-associated protein Nir2 (Litvak et al., 2004) . Plk1 was shown to depend on phosphorylated Nir2 for decent localization to the central spindle. However, whereas MKlp1/CHO1 and MKlp2 require Plk1-phosphorylation, Nir2 requires Cdk1-phosphorylation for Plk1-binding. Furthermore, both Nir2-depletion or removal of the Cdk1-phosphorylation site in Nir2 resulted in failure to properly localize Plk1 to the midzone (Litvak et al., 2004) . In addition, Plk1 was shown to phosphorylate NudC, a dynein-associated nuclear movement protein that plays a role in cytokinesis (Zhou et al., 2003) . Clearly, multiple proteins are required to properly localize Plk1 to the central spindle. Such multiple requirements may arise as a consequence of complex formation between MKlp1, MKlp2, Nir2 and possibly NudC. Alternatively, Plk1 could be recruited to the central spindle by one class of proteins, while its sustained association to the central spindle is mediated by yet another protein.
Cdk1-directed polo-box recruitment might also apply to other proteins. Indeed, one of the chromosome passenger proteins, INCENP, harbors a Cdk1 consensus phosphorylation site that perfectly fits the requirements for a polo-box binding site and is probably able to bind Plk1 (Elia et al., 2003a) . Moreover, other Plk's localize to the central spindle. Ectopic expression of tagged Plk3 and Plk4, for instance, also shows they can localize to the spindle midzone (Conn et al., 2000; Hudson et al., 2001) . And although phosphorylation mutants of MKlp1, MKlp2 and Nir2 are presumably unable to bind the polo-box of Plk1 and clearly show defective localization of Plk1, it is also conceivable that such mutants prevent other Plk's from binding to the central spindle. Moreover, involvement of multiple Plk family members in mitotic exit would explain why phosphomutants of MKlp2 result in severe cytokinesis defects, while Plk1 depletion does not interfere with furrow ingression (van Vugt et al., 2004b) . In addition, the fact that overexpression of both Plk1 and Plk3 results in multinucleation suggests cytokinesis is regulated by multiple Plk's (Mundt et al., 1997; Conn et al., 2000) . Functional redundancy between Plk1 and Plk3 may also play a role in inheritance of cellular organelles during mitosis. Both Plk1 and Plk3 were suggested to regulate partitioning of Golgi-stacks during cell division (Sutterlin et al., 2001; Ruan et al., 2004) . In addition, Plk1 was shown to interact and phosphorylate the Golgi-associated proteins Grasp65 and Nir2 (Lin et al., 2000; Litvak et al., 2004) and Plk3 colocalizes to Golgimarkers Giantin. Finally, overexpression of Plk3 results in premature Golgi-partitioning (Ruan et al., 2004) . Whether Plk1 and Plk3 regulate distinct processes in Golgi partitioning remains unclear. However, the fact that Grasp65 is phosphorylated in vitro by Cyclin BCdk1 and the presence of a polo-box-binding site suggest that also here Cdk1 can direct phosphorylation of Plk's ( Figure 3) (Lin et al., 2000) .
While different molecular targets for Plk1 were identified that play a role in correct localization of Plk1 to the central spindle and cytokinesis, the exact function of Plk1 at the central spindle is still unclear. Clearly, interference with Plk1-substrates MKlp1, MKlp2, NudC or Nir2, as well as Plk1 itself results in defects in the final stages of cytokinesis rather then disturbing the whole cytokinesis process (Seong et al., 2002; Neef et al., 2003; Zhou et al., 2003; Litvak et al., 2004; Matuliene and Kuriyama, 2004; van Vugt et al., 2004b) . In addition, removal of the Plk1 phosphorylation sites in MKlp1/CHO1 or MKlp2 does not block furrow ingression, but prevents abscission, Figure 4 Mitotic exit. In anaphase, Plk1 relocalizes from kinetochores to the central spindle, similar to chromosome passenger proteins. This relocalization depends on functional Nir2, NudC, MKlp1 and MKlp2. In addition, NudC, MKlp1 and MKlp2 are directly phosphorylated by Plk1 and these phosphorylation events were shown to be required for successful cytokinesis. During anaphase, Plk1 is degraded through the Cdh1-activated APC/C. This degradation is required for proper cytokinesis, probably because activity of Plk1 (as was shown for Cyclin B-Cdk1 activity) inhibits some critical steps in cytokinesis. At least for MKlp2, phosphorylation by Plk1 was shown to decrease its microtubule-stabilizing effect during cytokinesis suggesting that Plk1 plays a role in this final step of cytokinesis (Neef et al., 2003; Liu et al., 2004) .
One possible mechanism through which Plk1 activity is linked to cytokinesis was provided by experiments in C. elegans. Cytokinesis in C. elegans requires complex formation between Zen-4 (homolog of the human MKlp1) and ZYG-4, a Rho GTPase activator (Jantsch-Plunger et al., 2000; Mishima et al., 2002) . Regulation of Rho, in turn, was shown to be required for successful cytokinesis (reviewed in . Recently, also human MKlp1 was shown to form a complex with a homologous RhoGAP (Mishima et al., 2002) . Regulation of this complex likely involves phosphorylation by both Cyclin B-Cdk1 and Plk1. Cyclin B-Cdk1 directly phosphorylates MKlp1 to inhibit its motor activity and prevent it from binding to the mitotic spindle (Mishima et al., 2004) . Plk1 also phosphorylates MKlp1 in vitro, and this phosphorylation was suggested to be required for successful cytokinesis (Liu et al., 2004) . Combining this observation with the fact that MKlp1 is required for Plk1 localization makes it tempting to speculate that this is another situation in which Plk1 phosphorylates target proteins that are primed by Cdk1-phosphorylation. However, the conserved Cdk1 phosphorylation sites in MKlp1 do not match the Polo-box binding consensus Ser-Ser/Thr-Pro. Moreover, Plk1 was reported to bind MKlp1 during anaphase, and proper MKlp1 localization during anaphase requires CDC14-mediated dephosphorylation of the Cdk1 sites (Mishima et al., 2004) . So how exactly Plk1 binds MKlp1 is unclear, but it seems unlikely that Plk1 uses Cdk1-directed phosphorylation to dock to MKlp1. Thus, whether Plk1 ultimately regulates Rho GTPase activity after priming Cdk1 phosphorylation, and whether this involves MKlp1, MKlp2 or both requires additional experimentation.
In contrast, there is also evidence to suggest that it is not Plk1 activity, but the efficient elimination of Plk1 that is required for proper mitotic exit. Disruption of a KEN-box motif in Plk1 prevents its degradation by the APC/C-Cdh1 and clearly delays mitotic exit (Lindon and Pines, 2004) . This was also suggested by the fact that Plk1 negatively regulates the microtubule-bundling capacity of Mklp2 (Neef et al., 2003) . Plk1 inactivation can thus contribute to increased microtubule bundling at the central spindle. Consequently, enhanced microtubule bundling can cause local decreases in microtubule concentration, which were suggested to precede cytokinesis (Dechant and Glotzer, 2003) .
Taken together, it appears important for successful cytokinesis that (1) Plk1 is localized correctly to the central spindle, and (2) Plk1 is degraded efficiently. To investigate whether these two processes are linked, further research is required, but the fact that APC/C also localizes to the central spindle argues in favor of a model in which midzone localization of Plk1 is required for its degradation (Kurasawa and Todokoro, 1999) . The difficulty in pinpointing a specific role for Plk's in cytokinesis has been the inability to analyse cytokinesis in the absence of Plk's, without affecting other mitotic processes. Using a dominant-negative approach, Seong and co-workers did find abortive cytokinesis, but in this assay the dominant-negative effect was not powerful enough to prevent bipolar spindle formation, and hence not a full Plk1 inactivation may be observed (Seong et al., 2002) . In addition, this dominant-negative approach using a Plk1 fragment harboring the polobox domain may interfere with the function of other Polo-like kinases and reveal general functions of Pololike kinases, not Plk1 specifically. RNAi-mediated depletion of Plk1 prevents these problems, but also this technique does not allow observations of late mitosis because of spindle checkpoint activation. When Plk1 depletion was combined with spindle checkpoint inactivation, no 2N daughter cells were produced (van Vugt et al., 2004b) . However, this effect could equally well be explained by the observed spindle problems, since spindle checkpoint inactivation in Plk1 proficient cells with a monopolar spindle pheno-copied this effect (Canman et al., 2003; van Vugt et al., 2004b) . More importantly, furrow ingression as well as midbodyformation did occur in these Plk1-depleted cells, indicating that Plk1 is not essential for these aspects of cytokinesis (van Vugt et al., 2004b) . Timed Plk1 inactivation in cells that obtain a bipolar spindle will be required to get a clean picture of Plk1 functions in cytokinesis.
Plk1 and cancer
Plk1 is overexpressed in a range of human tumors, including prostate tumors, ovarian carcinomas, hepatoblastomas and melanomas, and Plk1 overexpression was shown to coincide with bad prognosis (Kneisel et al., 2002; Weichert et al., 2004a, b; Yamada et al., 2004) . Therefore, Plk1 is useful as a prognostic marker for outcome of disease. In addition, overexpression of Plk1 in murine cells drives tumorigenesis underlining the strong proliferation-stimulating effect of Plk1 (Smith et al., 1997) . Interestingly, whereas most studies correlate overexpression of Plk1 with cancer, certain tumor-associated mutations were found that destabilize Plk1 (Simizu and Osada, 2000) . The fact that Plk1 expression as well as its activity is obviously altered in transformed cells has prompted the use of Plk1-inhibition as a possible anticancer therapy. When antiPlk1 antibodies were injected into transformed and primary human cells, a striking difference was observed. Whereas transformed cells arrested in mitosis, primary cells arrested in G2 (Lane and Nigg, 1996) . Others described the use of dominant-negative fragments of Plk1, delivered through transfection or linkage to antennapedia-fragments (Seong et al., 2002; Yuan et al., 2002b) . Again, both these techniques indicated a strong requirement for Plk1 in mitotic progression as well as proliferation. More recently, RNA interference was used to block Plk1 function. Using synthetic dsRNAs as well as short hairpin RNAs, Plk1-depletion was shown to efficiently block cell growth of cultured tumor cells (Spankuch-Schmitt et al., 2002; Liu and Erikson, 2003; van Vugt et al., 2004b) . In addition, siRNA-producing vectors injected in nude mice significantly reduced growth of human tumor cells in a xenograft model (Spankuch et al., 2004) . The ultimate challenge, however, remains to investigate tumor growth of transformed cells, surrounded by normal somatic cells of the same species that are sensitive to the same siRNA. This way, possible undesired effects of Plk1 inhibition on normal somatic cell divisions can be studied in detail.
Spindle poisons are frequently used in the treatment of human cancer. These drugs cause a spindle checkpoint-mediated arrest, similar to what is observed in Plk1-depleted cells (van Vugt et al., 2004b) . Therefore, one might reason that inhibition of Plk1 could be helpful in cancer-therapy. However, although Plk1-depletion appears to efficiently inhibit proliferation of tumor cells, systemically depleting Plk1 would appear to be a dangerous track, as interference with Plk1 activity is also expected to result in severe problems in centrosome functioning in primary cells. This could potentially cause aberrant mitoses and result in chromosome instability in normal tissues that could contribute to de novo tumor formation.
A second possible strategy involves antitumor therapy through the G2/M DNA damage checkpoint. Genotoxic therapy can eliminate tumor cells via the DNA damage checkpoint in G2. Since Plk1 activity is required for checkpoint recovery after a G2 DNA damage arrest, inhibition of Plk1 in combination with genotoxic therapies would enforce a more stringent G2 arrest and prevent recovery of damaged cells (van Vugt et al., 2004a) . However, as discussed before, Plk1 inhibition may also lead to an aberrant mitosis and subsequent chromosomal instability in both tumor and normal tissue. With this in mind, it may be better to try to develop a strategy to interfere exclusively with the function of Plk1 at mitotic entry in recovering cells, rather than using inhibitors that inhibit Plk1 as a whole. To accomplish this, one could specifically target those Plk1-substrate interactions that are important for mitotic entry, leaving other polo box-mediated interactions intact. Obviously, a better understanding of the polo-box/phosphopeptide interaction will be required to accomplish this. Alternatively, a simpler approach may be to inhibit Cdc25B in combination with genotoxic therapy. Cdc25B is also required for cells to recover from a DNA damage checkpoint arrest (van Vugt et al., 2004a) . However, contrary to Plk1, interference with the function of Cdc25B does not appear to have a major impact on cell cycle progression in unperturbed cells (van Vugt et al., 2004a) . This is further supported by the finding that mice lacking functional Cdc25B are viable and healthy (Lincoln et al., 2002) . Therefore, inhibition of Cdc25B appears to be an attractive target for combinational therapy without running the risk of provoking tumor onset through genetic instability.
As a third alternative, Plk1 could be used as a target for adjuvant therapy. Conventional spindle poisons (such as paclitaxel) may be more effective in killing tumor cells, when cells are not delayed at the G2/M transition. Since Plk1 was suggested (albeit debated) to be a target of the prophase checkpoint that prevents mitotic entry in response to microtubule stress imposed by spindle poisons, it could be useful to overcome this negative effect on Plk1 activity. Similarly, a G2 DNA damage checkpoint override, causing cells to enter mitosis with residual DNA damage almost invariably leads to cell death. Therefore, preserving Plk1 activity in cells treated with genotoxic drugs may enhance cell killing through mitotic catastrophe. This might be accomplished by specific inhibition of the DNA damage checkpoint pathways that can inactivate Plk1 activity in response to damaging agents. However, to interfere with such a specific interaction, further research is warranted to elucidate the molecular mechanisms by which Plk1 is inactivated under these conditions.
Discussion and future directions
The answer to the intriguing question as to how one protein can regulate so many processes lies (at least in part) in localization. Plk1's unique localization pattern is largely mediated by its phospho-binding polo-box and an increasing number of reports illustrate the binding of Plk1 polo-boxes to substrates that primed through phosphorylation by other kinases (Figure 3) . Based on the work of Elia et al. (2003a) , Plk1 is expected to dock to a phosphorylated Cdk1 consensus motif, which would limit Plk1 actions to late G2, prometaphase and metaphase cells. Especially the roles for Plk1 in late mitotic events, such as cytokinesis, cannot easily be explained by Cdk-mediated priming. However, different reports have now shown that Polo-like kinases also bind to substrates that are primed by mitotic non-Cdk kinases, notably Plk1 itself (Figure 3) (Neef et al., 2003) . In addition, the nonmitotic kinase, ATR, was also shown to create a Plk1-binding site (Figure 2) (Yoo et al., 2004) . Whether other nonmitotic or mitotic kinases, such as Aurora kinases, can direct Plk1 localization, or whether phosphorylation-independent recruitment can also take place is currently unknown. However, the fact that Plk1 remains centrosomeassociated from G2 until mitotic exit does argue in favor of this latter idea.
While the majority of research concerning Plk's and cell cycle regulation deals with Plk1, also Sak (Plk4) might be an important mitotic regulator (Hudson et al., 2001) . As observed for Plk1, Sak localizes to mitotic structures via its polo box domain (Leung et al., 2002) . Moreover, mice lacking Sak are early embryonic lethal, and display increased numbers of mitotic cells (Hudson et al., 2001) . However, it is not likely that Plk1 and Sak are active in similar pathways and are functionally completely redundant, since deletion of Sak or depletion of Plk1 both result in mitotic defects. Another interesting feature of these Plk's is the differential organization of the polo-box domain; whereas Plk1 contains two polo-boxes, Sak only has one (Leung et al., 2002) . Since both polo-boxes in Plk1 were shown to participate in binding to a phosphorylated target-protein, it will be interesting to see whether monomers or dimers of Sak molecules function as a phospho-specific binding motif.
In conclusion, more and more targets of Plk1 are identified and, more importantly, the molecular modes of action of Plk1-target interactions are revealed. These recent results show that the interplay between Plk1 and other kinases controls recruitment and activation of Plk1 on certain subcellular structures and explain how one kinase can regulate so many different processes in a timely and spatially controlled fashion.
